Kronos Bio's market cap is currently $61.55M. The company's EPS TTM is $-1.441; its P/E ratio is ―; Kronos Bio is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 6.29M	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 6.29M	$ -4.46M	$ -4.08M	$ -4.87M	$ -605.00K
Operating Income	$ -121.83M	$ -137.12M	$ -151.40M	$ -58.04M	$ -16.82M
EBITDA	$ -119.69M	$ -128.74M	$ -147.00M	$ -79.69M	$ -15.51M
Net Income	$ -112.67M	$ -129.29M	$ -149.10M	$ -64.09M	$ -15.42M
Balance Sheet
Cash & Short-Term Investments	$ 173.00M	$ 247.95M	$ 339.51M	$ 462.06M	$ 92.18M
Total Assets	$ 213.28M	$ 294.94M	$ 391.48M	$ 511.96M	$ 102.69M
Total Debt	$ 28.27M	$ 31.09M	$ 33.76M	$ 32.06M	$ 528.00K
Net Debt	$ -36.05M	$ -44.88M	$ -305.75M	$ -430.00M	$ -32.04M
Total Liabilities	$ 54.20M	$ 50.44M	$ 46.38M	$ 46.45M	$ 125.89M
Stockholders' Equity	$ 159.08M	$ 244.50M	$ 345.10M	$ 465.52M	$ -23.20M
Cash Flow
Free Cash Flow	$ -79.26M	$ -91.50M	$ -122.18M	$ -47.48M	$ -18.03M
Operating Cash Flow	$ -78.58M	$ -90.93M	$ -117.92M	$ -37.91M	$ -15.08M
Investing Cash Flow	$ 66.37M	$ -32.22M	$ 63.72M	$ -160.24M	$ -67.58M
Financing Cash Flow	$ 567.00K	$ 851.00K	$ 4.46M	$ 415.61M	$ 105.01M

Currency in USD

Kronos Bio Earnings and Revenue History

Income Statement >

Kronos Bio Debt to Assets

Balance Sheet >

Kronos Bio Cash Flow

Cash Flow >

Kronos Bio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing